PRISM BioLab, enters into a Joint Research and Licensing Agr

PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target selected by Ono

Related Keywords

Tokyo , Japan , Osaka , Japanese , Dai Takehara , Seishi Katsumata , Eisai Co Ltd , Ono Pharmaceutical Co Ltd , Biolab Co Ltd , Discovery Research Of Ono , Ohara Pharmaceuticals Co Ltd , Executive Director , Region ,